Medical Condition News

RSS

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

EKF, announces publication of a new white paper detailing the successful external evaluation of its Quo-Test and Quo-Lab glycated hemoglobin analyzers.

From EKF Diagnostics 23 Oct 2013

EORTC/GIMEMA trial shows combination of GO and chemotherapy provides no benefit for older patients with AML

Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential combination of gemtuzumab ozogamicin (GO) and standard chemotherapy provides no benefit for older patients with acute myeloid leukemia (AML) and is too toxic for patients 70 years of age or more. GO is an antibody-drug conjugate comprised of an anti-CD33 monoclonal antibody linked to a cytotoxic agent.

23 Oct 2013

Functional biomarker could help guide treatment of patients with BRAF-mutant melanomas

A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment of patients with these cancers, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19 - 23.

23 Oct 2013

Special issue highlights crucial problem of obesity in children and adolescents

New studies of factors affecting the risk of obesity in children and adolescents—as well as promising approaches to prevention and treatment—are assembled in the special October Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics.

23 Oct 2013

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

A new diagnostic platform to detect BRAF mutations in melanoma and other cancer types is faster and more accurate compared with the standard method currently used in clinics, and this could help accelerate diagnosis and treatment, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

SENSE Theatre program improves social deficits in adolescents with autism

A novel autism intervention program using theatre to teach reciprocal communication skills is improving social deficits in adolescents with the disorder that now affects an estimated one in 88 children, Vanderbilt University researchers released today in the journal Autism Research.

23 Oct 2013

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

GenSpera, Inc. (OTCBB:GNSZ) announced that Devalingam Mahalingam, MD, PhD, principal investigator of the G-202 Phase II trial in hepatocellular carcinoma, presented final data from the G-202 Phase I clinical trial yesterday at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, MA.

23 Oct 2013

Carcinogens detected in emissions downwind of 'Industrial Heartland'

Levels of contaminants higher than in some of the world's most polluted cities have been found downwind of Canada's largest oil, gas and tar sands processing zone, in a rural area where men suffer elevated rates of cancers linked to such chemicals.

23 Oct 2013

Study highlights new treatment options for neurodevelopmental disorders like TSC

Clemson University scientists are working to determine how neurons are generated, which is vital to providing treatment for neurological disorders like Tuberous Sclerosis Complex (TSC).

23 Oct 2013

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

IBM scientists are collaborating with pathologists at the University Hospital Zurich to test a new prototype tool to accurately diagnose different types of cancer. This work is based on a technology developed by IBM scientists called a microfluidic probe, which slightly resembles the nib of a fountain pen.

23 Oct 2013

Meditation shows improved outcomes in patients with medically unexplained symptoms

A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in disturbances that do not find medical explanation.

23 Oct 2013

Study shows mindfulness-oriented intervention may reduce chronic pain in adults

A randomized controlled study published in the current issue of Psychotherapy and Psychosomatics has investigated the role of a special form of meditation (mindfulness) in Chronic pain.

23 Oct 2013

ASN strongly recommends all adults to undergo routine screening for chronic kidney disease

The American Society of Nephrology strongly recommends that all adults undergo routine screening for chronic kidney disease (CKD), the 8th leading cause of death in the U.S. This contradicts screening guidelines recently released by the American College of Physicians (ACP).

23 Oct 2013

Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients with brain metastases

Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.

23 Oct 2013

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

The flu vaccine may not only ward off serious complications from influenza, it may also reduce the risk of heart attack or stroke by more than 50 per cent among those who have had a heart attack, according to new research led by Dr. Jacob Udell, a cardiologist at Women's College Hospital and clinician-scientist at the University of Toronto. What's more, the vaccine's heart protective effects may be even greater among those who receive a more potent vaccine.

23 Oct 2013

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Receiving an influenza vaccination was associated with a lower risk of major adverse cardiovascular events such as heart failure or hospitalization for heart attack, with the greatest treatment effect seen among patients with recent acute coronary syndrome (ACS; such as heart attack or unstable angina), according to a meta-analysis published in the October 23/30 issue of JAMA.

23 Oct 2013

Study examines association between suicidal vulnerability and analgesic consumption in elderly

A paper published in the current issue of Psychotherapy and Psychosomatics has investigated the relationship between pain killers and suicidal behavior in the elderly.

23 Oct 2013

Study evaluates role of enteroviruses in human type 1 diabetes

Type 1 diabetes is a disease caused by the destruction of the insulin-producing cells in the pancreas. It is often diagnosed in childhood and requires life-long treatment with daily insulin injections. It is associated with an increased risk for long-term complications which decrease the quality of life and average life-expectancy.

23 Oct 2013

Clinical trial to investigate if vitamin D supplement helps prevent type 2 diabetes

Researchers have begun the first definitive, large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay type 2 diabetes in adults who have prediabetes, who are at high risk for developing type 2. Funded by the National Institutes of Health, the study is taking place at about 20 study sites across the United States.

23 Oct 2013

Medical Condition News

EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

EORTC/GIMEMA trial shows combination of GO and chemotherapy provides no benefit for older patients with AML

Functional biomarker could help guide treatment of patients with BRAF-mutant melanomas

Special issue highlights crucial problem of obesity in children and adolescents

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

New MDx prototype platform can detect BRAF V600 mutations in 90 minutes

SENSE Theatre program improves social deficits in adolescents with autism

GenSpera presents final data from G-202 Phase I clinical trial at EORTC-NCI-AACR Symposium

Carcinogens detected in emissions downwind of 'Industrial Heartland'

Study highlights new treatment options for neurodevelopmental disorders like TSC

IBM joins with University Hospital Zurich to test new prototype tool for diagnosing cancer

Meditation shows improved outcomes in patients with medically unexplained symptoms

Study shows mindfulness-oriented intervention may reduce chronic pain in adults

ASN strongly recommends all adults to undergo routine screening for chronic kidney disease

Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients with brain metastases

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Study examines association between suicidal vulnerability and analgesic consumption in elderly

Study evaluates role of enteroviruses in human type 1 diabetes

Clinical trial to investigate if vitamin D supplement helps prevent type 2 diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News